Tumor-specific Ythdf2 loss suppresses tumor growth, prolongs survival, recruits macrophages via CX3CL1, reduces glycolysis, enhances CD8+ T-cell mitochondrial respiration, and promotes pro-inflammatory macrophage polarization and antigen presentation. This evidence concerns the gene CX3CL1 and neoplasm.